Psilocybin compositions
AssigneeTurtle Bear Holdings, LLC
InventorPaul Edward Stamets
Life of this patent
Estimating the term…
Abstract
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
Claims18
A pharmaceutical formulation comprising of:
- 0.1 mg to 10 mg of psilocybin or psilocin;
- and an extract of Hericium erinaceus comprising 0.1 mg to 200 mg of erinacines or hericenones.
A pharmaceutical formulation comprising of:
- 0.1 mg to 10 mg of psilocybin or psilocin;
- an extract of Hericium erinaceus comprising 0.1 mg to 200 mg of erinacines or hericenones;
- and 1 mg to 50 mg of niacin.
A pharmaceutical formulation comprising of:
- 0.1 mg to 10 mg psilocybin or psilocin;
- and 1 mg to 50 mg of niacin.
A pharmaceutical dosage comprising a tablet, capsule, elixir, or suspension comprising of:
- 0.1 mg to 10 mg psilocybin or psilocin;
- an extract of Hericium erinaceus comprising 0.1 mg to 200 mg of erinacines or hericenones;
- and 1 mg to 50 mg of niacin.
Dependencies are inferred from the claim text.